Dr. Gerald Diaz @GeraldMD
23.4M 13.8K 7.2K
Board Certified Internal Medicine Hospitalist, GrepMed Editor in Chief 🇵🇭 🇺🇸 - Sign up for an account to like, bookmark and upload images to contribute to our community platform. Follow us on IG: https://www.instagram.com/grepmed/ | Twitter: https://twitter.com/grepmeded/
Contributor Ranks
Latest Searches
11 results
treatment hivaids opportunistic mycobacterium aud aviumcomplex candida candidiasis capsulatum cmv cryptococcosis cryptococcus cytomegalovirus diabetes disorder endocrinology esophageal histoplasma histoplasmosis isosporabelli
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... followed by chronic maintenance ... Penicilliosis #IDSA ... #management #opportunistic ... #pharmacology
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS Treating Isospora belli Infection General Management Considerations: • Fluid
IDSA Recommendations ... General Management ... IsosporaBelli #IDSA ... #Prevention #Treatment ... #pharmacology
Alcohol Use Disorder - Maintenance Treatment Naltrexone (first line) - First line for most people without contraindications
Alcohol Use Disorder ... - Maintenance Treatment ... #Treatment #management ... #pharmacology # ... table #addiction
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS Preventing CMV Disease: • CMV end-organ disease is best
IDSA Recommendations ... best prevented by using ... Followed by Chronic Maintenance ... #management #opportunistic ... #pharmacology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS Treating Visceral Leishmaniasis - Preferred Therapy: •
IDSA Recommendations ... Leishmaniasis #Prevention ... #Treatment #management ... opportunistic #infections ... #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Cryptococcosis in HIV-AIDS Treatment for cryptococcosis consists of 3 phases: induction,
IDSA Recommendations ... for Preventing ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days) Preferred
IDSA Recommendations ... #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS Indications for Initiating Primary Prophylaxis: •
for Preventing ... clinically improved Maintenance ... with ARV (see Table ... #management #opportunistic ... #pharmacology
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist Dosing: 3 mg daily x 30 days, then 7 mg
GLP-1 Agonist Dosing ... days, then 7 mg maintenance ... drug to remain stable ... patients to take meds ... semaglutide #Diabetes #Pharmacology
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS Preventing 1st Episode of Disseminated
please refer to Table ... 5 for dosing recommendation ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
empty